Add to ORKGIntroduction: Disease interactions can alter functional decline near the end of life (EOL). Parkinson’s disease (PD) is characterized by frequent occurrences of co-morbidities but data challenges have limited studies investigating co-morbidities across a broad range of diseases. The goal of this study was to describ
In a set of a population-based study, long-term survival of 59 prevalent PD patients was compared wi...
Parkinson's disease (PD) is often associated with other disorders, typical of the disease or of the ...
Parkinson’s disease (PD) is a common neurodegenerative disease, affecting approximately 1.8% of the ...
AbstractBackgroundMany aspects of co-morbidity burden in Parkinson’s disease (PD) are unclear, but i...
BACKGROUND: Earlier research showed that Parkinson's disease is related to increased overall mortali...
Background. Prognosis of PD is variable. Most studies show higher mortality rates in PD patients com...
Mortality rate, life expectancy, survival, and the impact of comorbidities on them in people with Pa...
Parkinson’s disease (PD) is a chronic progres-sive neurological disorder that frequently results in ...
Background: previous studies on mortality of Parkinson's disease (PD) enrolled a relatively small nu...
Copyright © 2014 John C. Morgan et al.This is an open access article distributed under theCreative C...
Reports of trends in mortality from neurodegenerative disease have long relied on death certificates...
Two hundred and forty-nine patients with Parkinson's disease previously examined by Mutch et al 1,2 ...
Background: Good medical care results in long survival for patients with Parkinson’s disease (PD). H...
Objective: To examine if indices of Parkinson’s disease (PD) pathology and other brain pathologies a...
Parkinson’s disease Parkinson’s disease (PD) is a degenerative movement disorder affecting 1 % to 2 ...
In a set of a population-based study, long-term survival of 59 prevalent PD patients was compared wi...
Parkinson's disease (PD) is often associated with other disorders, typical of the disease or of the ...
Parkinson’s disease (PD) is a common neurodegenerative disease, affecting approximately 1.8% of the ...
AbstractBackgroundMany aspects of co-morbidity burden in Parkinson’s disease (PD) are unclear, but i...
BACKGROUND: Earlier research showed that Parkinson's disease is related to increased overall mortali...
Background. Prognosis of PD is variable. Most studies show higher mortality rates in PD patients com...
Mortality rate, life expectancy, survival, and the impact of comorbidities on them in people with Pa...
Parkinson’s disease (PD) is a chronic progres-sive neurological disorder that frequently results in ...
Background: previous studies on mortality of Parkinson's disease (PD) enrolled a relatively small nu...
Copyright © 2014 John C. Morgan et al.This is an open access article distributed under theCreative C...
Reports of trends in mortality from neurodegenerative disease have long relied on death certificates...
Two hundred and forty-nine patients with Parkinson's disease previously examined by Mutch et al 1,2 ...
Background: Good medical care results in long survival for patients with Parkinson’s disease (PD). H...
Objective: To examine if indices of Parkinson’s disease (PD) pathology and other brain pathologies a...
Parkinson’s disease Parkinson’s disease (PD) is a degenerative movement disorder affecting 1 % to 2 ...
In a set of a population-based study, long-term survival of 59 prevalent PD patients was compared wi...
Parkinson's disease (PD) is often associated with other disorders, typical of the disease or of the ...
Parkinson’s disease (PD) is a common neurodegenerative disease, affecting approximately 1.8% of the ...